Literature DB >> 10734046

Cloning and characterization of a functional peroxisome proliferator activator receptor-gamma-responsive element in the promoter of the CAP gene.

C A Baumann1, N Chokshi, A R Saltiel, V Ribon.   

Abstract

c-Cbl-associating protein (CAP) is a multifunctional signaling protein that interacts with c-Cbl, facilitating the tyrosine phosphorylation of c-Cbl in response to insulin. In 3T3-L1 adipocytes and diabetic rodents, CAP gene expression is stimulated by activators of peroxisome proliferator activator receptor gamma (PPARgamma), such as thiazolidinediones (TZDs), resulting in increased insulin-stimulated c-Cbl phosphorylation. Sequence analysis of 2.5 kilobases of the 5'-flanking region of the CAP gene reveals a predicted peroxisome proliferator response element (PPRE) from -1085 to -1097. The isolated promoter was functional in 3T3 fibroblasts and adipocytes. Co-transfection of the CAP promoter with PPARgamma and retinoic acid X receptor alpha caused fold stimulation of promoter activity. The TZD rosiglitazone produced an additional 2-3-fold stimulation of the promoter. Deletion of the predicted PPRE from the CAP promoter abolished its ability to respond to rosiglitazone. Gel shift analysis of the putative PPARgamma site demonstrates direct binding of PPAR/retinoid X receptor heterodimers to the PPRE in the CAP gene. These data demonstrate that TZDs directly stimulate transcription of the CAP gene through activation of PPARgamma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10734046     DOI: 10.1074/jbc.275.13.9131

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Cloning and characterization of Cbl-associated protein splicing isoforms.

Authors:  Mei Zhang; Akiko Kimura; Alan R Saltiel
Journal:  Mol Med       Date:  2003 Jan-Feb       Impact factor: 6.354

2.  Cross-Talk between PPARgamma and Insulin Signaling and Modulation of Insulin Sensitivity.

Authors:  Anna Leonardini; Luigi Laviola; Sebastio Perrini; Annalisa Natalicchio; Francesco Giorgino
Journal:  PPAR Res       Date:  2010-02-23       Impact factor: 4.964

Review 3.  Rosiglitazone: a review of its use in the management of type 2 diabetes mellitus.

Authors:  Antona J Wagstaff; Karen L Goa
Journal:  Drugs       Date:  2002       Impact factor: 9.546

4.  Identification of CAP as a costameric protein that interacts with filamin C.

Authors:  Mei Zhang; Jun Liu; Alan Cheng; Stephanie M Deyoung; Alan R Saltiel
Journal:  Mol Biol Cell       Date:  2007-09-26       Impact factor: 4.138

5.  Type II diabetes mellitus and cardiovascular risk factors: Current therapeutic approaches.

Authors:  Christos Kalofoutis; Christina Piperi; Anastasios Kalofoutis; Fred Harris; David Phoenix; Jaipaul Singh
Journal:  Exp Clin Cardiol       Date:  2007

6.  Metformin regulates glucose transporter 4 (GLUT4) translocation through AMP-activated protein kinase (AMPK)-mediated Cbl/CAP signaling in 3T3-L1 preadipocyte cells.

Authors:  Jung Ok Lee; Soo Kyung Lee; Ji Hae Kim; Nami Kim; Ga Young You; Ji Wook Moon; Su Jin Kim; Sun Hwa Park; Hyeon Soo Kim
Journal:  J Biol Chem       Date:  2012-11-07       Impact factor: 5.157

7.  Human immunodeficiency virus (HIV)-1 viral protein R suppresses transcriptional activity of peroxisome proliferator-activated receptor {gamma} and inhibits adipocyte differentiation: implications for HIV-associated lipodystrophy.

Authors:  Shashi Shrivastav; Tomoshige Kino; Tshaka Cunningham; Takamasa Ichijo; Ulrich Schubert; Peter Heinklein; George P Chrousos; Jeffrey B Kopp
Journal:  Mol Endocrinol       Date:  2007-10-11

Review 8.  Modulation of the transcriptional activity of peroxisome proliferator-activated receptor gamma by protein-protein interactions and post-translational modifications.

Authors:  Tae-Hyun Kim; Mi-Young Kim; Seong-Ho Jo; Joo-Man Park; Yong-Ho Ahn
Journal:  Yonsei Med J       Date:  2013-05-01       Impact factor: 2.759

9.  Differential expression and alternative splicing of transcripts in orbital adipose/connective tissue of thyroid-associated ophthalmopathy.

Authors:  Lianqun Wu; Yu Liang; Nan Song; Xiying Wang; Chao Jiang; Xinxin Chen; Bing Qin; Xiantao Sun; Guohua Liu; Chen Zhao
Journal:  Exp Biol Med (Maywood)       Date:  2021-06-02

10.  Non-DNA binding, dominant-negative, human PPARgamma mutations cause lipodystrophic insulin resistance.

Authors:  Maura Agostini; Erik Schoenmakers; Catherine Mitchell; Istvan Szatmari; David Savage; Aaron Smith; Odelia Rajanayagam; Robert Semple; Jian'an Luan; Louise Bath; Anthony Zalin; Mourad Labib; Sudhesh Kumar; Helen Simpson; Dirk Blom; David Marais; John Schwabe; Inês Barroso; Richard Trembath; Nicholas Wareham; Laszlo Nagy; Mark Gurnell; Stephen O'Rahilly; Krishna Chatterjee
Journal:  Cell Metab       Date:  2006-10       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.